With Strong Clinical Data Established, Traders Should Act Fast to Capture Gains in Leap Therapeutics (LPTX) Stock
As Leap shores up its capital position and targets tumors with data-driven trials, LPTX stock could grow by leaps and bounds The onset of Covid-19